Logo image of ECCX

EAGLE POINT CREDIT CO - ECC 6.6875 04/30/28 (ECCX) Stock Fundamental Analysis

NYSE:ECCX - New York Stock Exchange, Inc. - US2698095054 - Currency: USD

24.56  +0.21 (+0.86%)

Fundamental Rating

3

Taking everything into account, ECCX scores 3 out of 10 in our fundamental rating. ECCX was compared to 0 industry peers in the Unkown industry. ECCX has a bad profitability rating. Also its financial health evaluation is rather negative. ECCX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ECCX was profitable.
ECCX had a negative operating cash flow in the past year.
Of the past 5 years ECCX 4 years were profitable.
In the past 5 years ECCX reported 4 times negative operating cash flow.
ECCX Yearly Net Income VS EBIT VS OCF VS FCFECCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M

1.2 Ratios

Industry RankSector Rank
ROA 5.33%
ROE 7.56%
ROIC 5.84%
ROA(3y)1.32%
ROA(5y)6.59%
ROE(3y)1.24%
ROE(5y)9.12%
ROIC(3y)6.93%
ROIC(5y)6.24%
ECCX Yearly ROA, ROE, ROICECCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

ECCX's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of ECCX has grown nicely.
ECCX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 59.47%
PM (TTM) 44.67%
GM 62.95%
OM growth 3Y5.72%
OM growth 5Y2.96%
PM growth 3Y-33.04%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.17%
ECCX Yearly Profit, Operating, Gross MarginsECCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, ECCX has more shares outstanding
ECCX has more shares outstanding than it did 5 years ago.
ECCX has a worse debt/assets ratio than last year.
ECCX Yearly Shares OutstandingECCX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ECCX Yearly Total Debt VS Total AssetsECCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

ECCX has an Altman-Z score of 4.08. This indicates that ECCX is financially healthy and has little risk of bankruptcy at the moment.
ECCX has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 4.08
ROIC/WACCN/A
WACCN/A
ECCX Yearly LT Debt VS Equity VS FCFECCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

ECCX has a Current Ratio of 1.59. This is a normal value and indicates that ECCX is financially healthy and should not expect problems in meeting its short term obligations.
ECCX has a Quick Ratio of 1.59. This is a normal value and indicates that ECCX is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.59
ECCX Yearly Current Assets VS Current LiabilitesECCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ECCX have decreased strongly by -13.97% in the last year.
ECCX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.24% yearly.
ECCX shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.26%.
The Revenue has been growing by 22.03% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-13.97%
EPS 3Y-5.35%
EPS 5Y-2.24%
EPS Q2Q%-27.27%
Revenue 1Y (TTM)29.26%
Revenue growth 3Y26.64%
Revenue growth 5Y22.03%
Sales Q2Q%25.75%

3.2 Future

Based on estimates for the next years, ECCX will show a decrease in Earnings Per Share. The EPS will decrease by -9.93% on average per year.
ECCX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.87% yearly.
EPS Next Y-10.15%
EPS Next 2Y-9.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year24.6%
Revenue Next 2Y16.87%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ECCX Yearly Revenue VS EstimatesECCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ECCX Yearly EPS VS EstimatesECCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.99, which indicates a rather expensive current valuation of ECCX.
ECCX is valuated rather cheaply when we compare the Price/Earnings ratio to 26.86, which is the current average of the S&P500 Index.
ECCX is valuated rather expensively with a Price/Forward Earnings ratio of 23.36.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.43, ECCX is valued at the same level.
Industry RankSector Rank
PE 20.99
Fwd PE 23.36
ECCX Price Earnings VS Forward Price EarningsECCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECCX Per share dataECCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

A cheap valuation may be justified as ECCX's earnings are expected to decrease with -9.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.93%
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.48%, ECCX is a good candidate for dividend investing.
ECCX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 8.48%

5.2 History

ECCX has been paying a dividend for over 5 years, so it has already some track record.
ECCX has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
ECCX Yearly Dividends per shareECCX Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

204.02% of the earnings are spent on dividend by ECCX. This is not a sustainable payout ratio.
DP204.02%
EPS Next 2Y-9.93%
EPS Next 3YN/A
ECCX Yearly Income VS Free CF VS DividendECCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M
ECCX Dividend Payout.ECCX Dividend Payout, showing the Payout Ratio.ECCX Dividend Payout.PayoutRetained Earnings

More info and screens

EAGLE POINT CREDIT CO - ECC 6.6875 04/30/28

NYSE:ECCX (6/26/2025, 7:36:55 PM)

24.56

+0.21 (+0.86%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-19 2025-05-19/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners8.98%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap2.95B
Analysts77.78
Price Target27.04 (10.1%)
Short Float %0%
Short Ratio1.37
Dividend
Industry RankSector Rank
Dividend Yield 8.48%
Yearly Dividend1.74
Dividend Growth(5Y)N/A
DP204.02%
Div Incr Years2
Div Non Decr Years2
Ex-Date06-16 2025-06-16 (0.418)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.74%
Min EPS beat(2)-13.9%
Max EPS beat(2)-13.58%
EPS beat(4)1
Avg EPS beat(4)-9.52%
Min EPS beat(4)-13.9%
Max EPS beat(4)1.47%
EPS beat(8)2
Avg EPS beat(8)-11.71%
EPS beat(12)3
Avg EPS beat(12)-9.68%
EPS beat(16)5
Avg EPS beat(16)-6.4%
Revenue beat(2)1
Avg Revenue beat(2)1.21%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)3.83%
Revenue beat(4)1
Avg Revenue beat(4)-1.69%
Min Revenue beat(4)-6.65%
Max Revenue beat(4)3.83%
Revenue beat(8)3
Avg Revenue beat(8)-2.27%
Revenue beat(12)6
Avg Revenue beat(12)-1.25%
Revenue beat(16)10
Avg Revenue beat(16)0.5%
PT rev (1m)-8.27%
PT rev (3m)-3.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.77%
EPS NY rev (1m)-2.36%
EPS NY rev (3m)-3.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.01%
Revenue NY rev (1m)1.56%
Revenue NY rev (3m)2.79%
Valuation
Industry RankSector Rank
PE 20.99
Fwd PE 23.36
P/S 16.42
P/FCF N/A
P/OCF N/A
P/B 2.78
P/tB 2.78
EV/EBITDA N/A
EPS(TTM)1.17
EY4.76%
EPS(NY)1.05
Fwd EY4.28%
FCF(TTM)-3.57
FCFYN/A
OCF(TTM)-3.57
OCFYN/A
SpS1.5
BVpS8.84
TBVpS8.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 7.56%
ROCE 7.39%
ROIC 5.84%
ROICexc 6.02%
ROICexgc 6.03%
OM 59.47%
PM (TTM) 44.67%
GM 62.95%
FCFM N/A
ROA(3y)1.32%
ROA(5y)6.59%
ROE(3y)1.24%
ROE(5y)9.12%
ROIC(3y)6.93%
ROIC(5y)6.24%
ROICexc(3y)7.33%
ROICexc(5y)6.51%
ROICexgc(3y)7.34%
ROICexgc(5y)6.51%
ROCE(3y)8.78%
ROCE(5y)7.89%
ROICexcg growth 3Y7.57%
ROICexcg growth 5Y-0.43%
ROICexc growth 3Y7.47%
ROICexc growth 5Y-0.49%
OM growth 3Y5.72%
OM growth 5Y2.96%
PM growth 3Y-33.04%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.17%
F-Score1
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 5.98
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.59
Altman-Z 4.08
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.97%
EPS 3Y-5.35%
EPS 5Y-2.24%
EPS Q2Q%-27.27%
EPS Next Y-10.15%
EPS Next 2Y-9.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)29.26%
Revenue growth 3Y26.64%
Revenue growth 5Y22.03%
Sales Q2Q%25.75%
Revenue Next Year24.6%
Revenue Next 2Y16.87%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.3%
EBIT growth 3Y33.88%
EBIT growth 5Y25.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-425.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-425.93%
OCF growth 3YN/A
OCF growth 5YN/A